Background {#Sec1}
==========

Phelan-McDermid syndrome (PMS) is a neurogenetic syndrome caused by haploinsufficiency of the *SHANK3* gene due to a spectrum of anomalies in the terminal region of the long arm of chromosome 22, ranging from single-nucleotide variants to large deletions affecting multiple genes \[[@CR1]\]. SHANK3 is a key structural protein in excitatory synapses, with several isoforms with different functions in development and in the synapse \[[@CR2], [@CR3]\]. Deletions or sequence variants of the *SHANK3* gene are associated with the neuropsychiatric manifestations of the syndrome and required for the diagnosis of PMS \[[@CR4]--[@CR7]\]. Individuals with PMS often present with intellectual disability (ID), features of autism spectrum disorder (ASD), hypotonia, and severely delayed or absent speech \[[@CR8]--[@CR10]\]. Genotype-phenotype studies in individuals with terminal deletions have found that the severity of speech impairment and intellectual disability increases with increasing deletion size \[[@CR8], [@CR9]\]. In one recent study examining phenotypic manifestations among 17 individuals with sequence variants within *SHANK3* \[[@CR7]\], the majority developed single words, and 44% had phrase speech, in contrast to more severe impairment in individuals with deletions.

Epilepsy is reported in 17% to 70% of individuals with PMS \[[@CR9], [@CR11]--[@CR14]\]. As individuals with PMS age, they appear to be at increased risk for bipolar disorder \[[@CR15]--[@CR20]\] and an associated risk of significant cognitive and behavioral regression \[[@CR5], [@CR6], [@CR16], [@CR18]--[@CR20]\]. Indeed, *SHANK3* variants have been implicated in the risk for severe neuropsychiatric disorders, including mood and psychotic disorders \[[@CR15], [@CR16], [@CR19], [@CR21], [@CR22]\]. Gauthier et al. (2010) identified sequence variants in the *SHANK3* gene in four individuals initially diagnosed with atypical, early-onset schizophrenia, and a history of borderline to mild intellectual disability \[[@CR21]\]. Catatonia, a unique syndrome of motor and autonomic dysregulation associated with a variety of psychiatric and medical conditions, has also been described in PMS \[[@CR7], [@CR15], [@CR22], [@CR23]\]. Of note, catatonia in pediatric populations and in individuals with developmental disabilities often goes unrecognized \[[@CR24]\] and poorly treated \[[@CR25]\].

A few previous cross-sectional studies have used systematic methods to characterize the behavioral profile of individuals with PMS across the lifespan \[[@CR19], [@CR26]--[@CR28]\]. However, the nature and course of psychiatric symptoms in PMS, and in particular their association with regression occurring much later than the early childhood regressions typical of ASD, have not been extensively documented. In this retrospective study, we collected developmental histories, behavioral profiles, and genetic findings of 38 adolescents and adults with PMS and psychiatric illness with the aim to (1) better characterize the psychiatric and developmental phenomena reported in PMS and (2) aid in early recognition and treatment optimization.

Methods {#Sec2}
=======

Participants and procedures {#Sec3}
---------------------------

The study was approved by the Institutional Review Board of the PMS International Registry (PMSIR) (<https://www.pmsf.org/registry/>). Informed consent for participation in the Registry was obtained from the parents or legal guardians of participants, who also signed a release for inclusion in publication, and for integration of their interview data with their PMSIR data. Families were recruited by outreach through the PMS Foundation community Facebook page, and families were specifically invited to participate if the individual with PMS had experienced distinct psychiatric changes, such as mood episodes, psychosis, marked changes in sleep and energy, major loss of skills, sudden new intense obsessive-compulsive behaviors, or other neuropsychiatric difficulties, with or without regression. Families either contacted the researcher (TMK) directly in response to the Facebook message or responded after other families relayed the recruitment message on Facebook to parents with possible clinical concerns as described. In addition to the 37 English-speaking families, six families were referred through the PMS Spanish Association, and two enrolled and completed the study procedures.

Thirty-seven caregivers completed interviews on 39 participants and provided informed consent; one participant was excluded from the analysis since criteria were not met for a distinct psychiatric episode. Three families had responded to the invitation but did not complete interviews or consent after an initial contact established that they did not meet criteria for a distinct psychiatric episode. The final sample included 38 individuals from 36 families, ranging in age from 13 to 50 at the time of contact. The sample includes two sets of monozygotic twins with both twins enrolled. Caregivers interviewed were mothers in all but one case, in which the respondent was a sibling who was the legal guardian. Interviews were conducted in English (*n* = 34) or Spanish (*n* = 2), and respondents lived in the USA (*n* = 29), Australia (*n* = 4), Canada (*n* = 1), England (*n* = 1), Netherlands (*n* = 1), and Spain (*n* = 2).

Measures {#Sec4}
--------

A semi-structured interview entitled the Caregiver Interview for Psychiatric Illness in Persons with ID (see Additional file [1](#MOESM1){ref-type="media"}) was developed by TMK and conducted with caregivers by child and adolescent psychiatrists (TMK for English interviews and MPT for Spanish interviews). The interview includes questions designed to elicit descriptions of the participant's developmental history, major health challenges, the emergence and course of episodes of psychiatric illness or regression, response to pharmacologic treatment, and current level of functioning. Interviews typically lasted 90 min. All final notes were reviewed and approved by the families before inclusion in the study.

Genetic reports were obtained for all participants and reviewed by the geneticist (CB) curating results for the PMSIR. PMSIR data were used to confirm genetic results for study participants and for comparisons of prevalence of genetic variants, age, and gender. However, only 21 of 38 participants in this study had completed the PMSIR clinical and developmental questionnaires, limiting direct comparisons of clinical data between study participants and other Registry members. Nine of 38 participants were not enrolled in the Registry prior to study participation.

Comparisons between functional status and developmental milestones in study participants vs Registry data included parent report of whether key developmental skills were ever achieved on the Caregiver Interview (for the study sample) and on the Registry's Developmental Questionnaire for a group of respondents of similar age, with Registry data excluding the participants who were enrolled in the current study.

Assessment of behavioral symptoms and labeling of psychiatric diagnoses in the context of neurodevelopmental disorders is complicated by cognitive and communicative limitations, atypical presenting features, and premorbid characteristics (e.g., echolalia, repetitive behaviors). The Diagnostic and Statistical Manual for Mental Disorders, 5th edition \[[@CR29]\] does not comprehensively include modifications of all diagnostic criteria for differential manifestations that may present in the context of intellectual disability, and there is a dearth of psychometrically rigorous instruments validated for psychiatric evaluation in this population. Therefore, we used the Diagnostic Manual - Intellectual Disability, Second Edition (DM-ID-2) \[[@CR30]\] to classify psychiatric episodes. The DM-ID-2 is based on the DSM, adapted to include caregiver observations of behavior and to reduce the number of symptoms required to make diagnoses where persons with intellectual disability may not be able to report experiences \[[@CR31]\]. All cases were reviewed by a child and adolescent psychiatrist (TMK) using a checklist of DM-ID-2 criteria for each of these disorders. The symptoms reported by caregivers during acute episodes met criteria for major depressive episode, manic episode, obsessive-compulsive disorder, generalized anxiety disorder, brief psychotic disorder, schizoaffective disorder, and catatonia associated with another mental disorder (see Additional file [2](#MOESM2){ref-type="media"}). In addition, two child and adolescent psychiatrists (MPT, AK) randomly reviewed and classified eight cases to assure accuracy of diagnostic classification. Agreement on the presence of a mood disorder was 100%, agreement on whether the first mood episode was depressive or manic was 88%, and agreement on the presence of catatonia was 88%.

The word "regression" is often used to describe a wide variety of states, including transient loss of skills during psychiatric episodes with and without catatonia. For clarity, "regression" was defined in this study as a prolonged loss of previously acquired skills that either (a) began when the individual was psychiatrically well or (b) began during a psychiatric episode, with loss of skills persisting for at least 6 months beyond the resolution of the psychiatric episode.

Results {#Sec5}
=======

Descriptive statistics and comparisons to participants in the PMSIR are reported in Table [1](#Tab1){ref-type="table"}. Summaries of case histories and genetic findings are reported in Table [2](#Tab2){ref-type="table"}. There was a strong female predominance in this sample (31 females, 7 males) whereas PMS typically affects males and females in equal proportion. There were 23 individuals with terminal deletions, with a mean size of 1.63 Mb (range 160 kb--6.41 Mb). Five deletions were secondary to a chromosomal rearrangement: a ring chromosome 22 in three individuals and an unbalanced translocation in two. Twelve individuals with terminal deletions had not had a karyotype, so the possibility of a ring chromosome 22 cannot be excluded. Fifteen individuals had pathogenic sequence variants in *SHANK3* (12 frameshift variants and 3 nonsense variants). Table 1Demographic and clinical variables in the study sample as compared to the Phelan-McDermid Syndrome International Registry (PMSIR) participants 13 or olderThis study (*n* = 38)PMSIR (*n* = 130)ComparisonMean age at data collection24.7 years ± 9.9220.8 years ± 7.65*t*(166) = 2.56, *p* = .011*χ*^2^(1) = 10.21, *p* = .001Gender Male18% (7/38)47% (61/130)*χ*^2^(1) = 10.20, p = .001 Female82% (31/38)53% (69/130)Genetic defect ^a^ Terminal deletion61% (23/38)91% (118/130)*χ*^2^(1) = 19.79, *p* \< .001 Interstitial deletion--2% (3/130)*SHANK3* sequence variant39% (15/38)7% (9/130)ASD diagnosis (ever)^d^55% (21/38)41% (37/91^b^)*χ*^2^(1) = 2.105, *p* = .147History afebrile seizure(s)39% (15/38)41% (37/91)*χ*^2^(1) = .044, *p* = .834Walked independently (ever)100% (38/38)81% (64/79^c^)*χ*^2^(1) = 8.212, *p* = .004Spoke in phrases or sentences (ever)79% (30/38)51% (40/79)*χ*^2^(1) = 8.317, *p* = .004Toileted independently "always" or "sometimes" (ever)89% (34/38)48% (38/79)*χ*^2^(1) = 18.029, *p* \< .001Dressed self independently (ever)78% (30/38)42% (33/79)*χ*^2^(1) = 13.26, *p* \< .001Chronic constipation84% (32/38)15% (14/91)*χ*^2^(1) = 55.428, *p* = \<.001Acute urinary retention47% (18/38)3% (3/87)*χ*^2^(1) = 37.091, *p* \< .001^a^Among all Registry participants (*n* = 509, excluding the study participants), there are 467 terminal deletions (92%), 10 interstitial deletions (2%) and 32 sequence variants (6%)^b^91 participants in this age range (excluding the study participants) completed the Registry Clinical Questionnaire^c^79 participants in this age range (excluding the study participants) completed the Registry Developmental Questionnaire^d^Prior to the onset of neuropsychiatric illness, 42% (16/38) of participants had ASD diagnosesTable 2Case summariesCase \#\
Gender\
Age at time of studyGenetic defectLevel of functioning prior to onset psychiatric illness ^1^Reported possible triggering stressorsAge onset psychiatric illness; psychiatric diagnoses by DM-ID-2 criteria; associated features; number of episodesAge and areas of regression after onset psychiatric illness ^2,\ 3^Years since last psychiatric episode and regression; degree of recovery in that time and skills regainedCase 1Female18 years 9 monthsTerminal deletion \[89 kb\]arr\[hg19\] 22q13.33(51,122,483-51,211,392)x1Phrase speechToilet trainedDressed selfFed selfIndependent for hygieneRead sight wordsCounted to 100None notedAge 14First episode depressed with new tics, fecal smearingThen, OCD, new pica, manic episode and catatoniaThree episodesAge 14Decreased speechDecreased eye contactNew onset incontinenceUnable to dress selfLost all academic skillsMood episode in past yearFour years since regressionMinimal recoveryOccasional meaningful speech and singingIntermittent feeding self with utensilCase 2Female29 years 6 monthsMosaic terminal deletion and interstitial duplication \[4.4 Mb\]46,XX; arr\[hg19\] 22q13.2q13.31(43,675,642-46,807,366)x3\[0.65\], 22q13.31q13.33(46,808,071-51,197,838)x1\[0.65\]Single wordsToilet trainedPretend play with dollsProgram transitionAge 27First episode depressed with catatoniaThen new generalized anxiety disorder (GAD)One mood episodeOngoing GADAge 27Decreased speechIncontinentDecreased independence in ADLsDecreased pretend playTwo years since mood episodeTwo years since regressionNo recoveryCase 3Female18 years 0 monthTerminal deletion--unbalanced translocation \[207 kb\]46,XX; arr\[hg19\] 3p26.3(180,509-2,097,153)x3,22q13.33(50,990,475-51,197,838)x1Spoke in full sentencesToilet trainedWrote simple textUsed iPadURIBeginning new schoolAge 12First episode OCD dx PANDAS Then depressed with new tics, tremors and posturing,Then mixed manic and depressed symptoms with new aggression, new anxiety at leaving houseFour episodes (three mood)Age 15Decreased speech clarityFrequent urinary incontinenceDecreased independence in ADLsMood episode in past yearThree years since regressionModerate recoveryStill unpredictably incontinentSpeech improved, still dysfluentCase 4Female22 years 3 monthsTerminal deletion -- ring 2246,XX,r \[[@CR22]\](p13q13.3).ish r \[[@CR22]\](ARSA-)Phrase speechNever toilet trainedDressed self with promptsRead some sight wordsDid puzzlesURIAge 16First episode depressive symptoms^5^Then manic symptoms with hand posturing and gait disturbanceThree mood episodesAge 16Decreased speechDecreased response to environmentDecreased orientationMood episode in past yearSix years since regressionSkills continue to deteriorateCase 5Male36 years 1 monthTerminal deletion \[106 kb\]46,XY; arr\[hg18\] 22q13.33(49,474,771-49,581,309)x1Full sentencesToilet trainedDressed selfDid all self-careIndependent with own routinesAble to return home from day program unassisted and to be home alone safelyProgram transitionAge 28First episode depressedThen new aggression whichworsened to require two hospitalizations and placement in nursing care facilityThree mood episodesAge 30Slowly regressed over several yearsLost speechDecreased continenceLost ability to dress and showerNeeds help with eatingMoved slowlyNo longer can be left aloneNo episode in past 3 yearsSix years since regressionModerate recoveryRemains largely mute and uses single words or gruntsDependent for ADLsRegained some self-care skillsImproved moodIncontinent at nightCase 6Female28 years 11 monthsTerminal deletion \[54 kb\]arr\[hg19\] 22q13.33(51,123,491-51,178,264)x1Spoke in full sentencesToilet trainedDressed selfMade snacksRead simple booksWrote simple textPneumoniaAge 14First episode depressedThen mania with complete insomnia for 12 days, catatonia, neuroleptic malignant syndrome and seizuresNow ECT dependent10+ mood episodesAge 26Sporadic incontinenceConfusedCouldn't read or writeDecreased hand skillsPoor memoryMood episode in past yearTwo years since regressionNo recoveryCase 7Female34 years 6 monthsTerminal deletion -- ring 2246,XX,r \[[@CR22]\](q13.3) with deletion of terminal 22qSimple repetitive speechToilet trainedDressed self with promptsSome sight wordsSome computer skillsNone notedAge 30First episode depressedThen both manic and depressed episodes10+ mood episodesAge 30Decreased vocalizationsFrequent incontinenceDecreased independence with dressingMood episode in past yearFour years since regressionModerate recoveryVocalizes moreRemains incontinentFeeds self but needs supervision for chokingNeeds help with dressingCase 8Female36 years 3 monthsTerminal deletion \[106 kb\]arr\[hg18\] 22q13.33 (49,475,238-49,581,309)×1Phrase speechToilet trainedDressed self with supervisionRead simple wordsPlayed with dollsNone notedAge 11First episode manic symptomsThen mixed mood episodes10+ mood episodesAge 11Steady developmental decline from age 11Lost almost all languageIncontinentLost use of utensilsNo longer dresses selfNo play interestsNo episode in past year25 years since regressionNo recoveryCase 9Female43 years 1 monthTerminal deletion -- ring 22 \[2.1 Mb\]46,XX,r \[[@CR22]\](p13q11.2); arr\[hg19\] 22q13.32q13.33(49,056,457-51,179,671)x1Spoke in full sentencesToilet trainedDressed selfIndependent for hygieneActive in programsNone notedAge 32Abrupt onset of stuporous catatonia with food phobiaThen multiple manic and depressed episodes10+ mood episodesAge 32Decreased speechIncontinentNo longer able to dress self or bathe selfMood episode in past year12 years since regressionMinimal recoveryDecreased speechIntermittent incontinenceNeeds supervision for self-careCase 10Female17 years 11 monthsSequence variant -- FrameshiftNM_033517.1:c.3424_3425delCT, p.Leu1142Valfs\*153Spoke in full sentencesToilet trainedDressed self and did most hygieneRead sight wordsWrote name, familiar words, copied textMensesStarted at new schoolAge 14First had three peri-menstrual manic episodes followed by paranoiaThen prolonged severe depression with catatonic featuresThen acute OCD with tics, posturing and choreiform movementsThen mania with first seizure and catatonia, dx seronegative autoimmune encephalitisSix episodes (five mood episodes)No lasting loss of skillsMood episode in past yearNo regressionCase 11Male14 years 11 monthsSequence variant -- FrameshiftNM_033517.1:c.3679dupG, p.Ala1227Glyfs\*69Phrase speechSocial and interactiveToilet trainedRead sight wordsTyped from a modelGastro-enteritisAge 12First episode manic with agitation, new pica, new incontinence, destructive behavior, mutism, and catatoniaThen OCD with agitation and aggressionFive+ mood episodesAge 12Lost most languageLess social and interactiveIncontinentLost all academic skillsNew obsessional and repetitive behaviorsMood episode in past yearTwo years since regressionMinimal recoveryRare speech and interaction nowStill incontinentCase 12Female43 years 8 monthsSequence variant -- FrameshiftNM_033517.1:c.4906_4921dup16, p.Pro1641Leufs\*58 dnSpoke in full sentencesToilet trainedDressed and washedRead at 3rd grade levelMath grade level through 9th gradeWorked at supported job in library and in town hospitalBalanced own checkbookMensesViral infectionsAge 11First episode mixed, with agitation, insomnia, cognitive dulling, posturingThen multiple mood episodes with catatonia20+ mood episodesAge 11Gradual, with each episode lost skills, twice lost ability to walk, would regain some skills with therapies, still working and verbal to age 28; after a severe cold lost all speech, continence, self-care and many motor skills, cannot use hands (dystonic posturing at wrists)No episode in past year15 years since most severe regressionNo recoveryCase 13Female14 years 1 monthTerminal deletion \[123 kb\]46,XX; arr\[hg18\] 22q13.33(49,468,254-49,591,415)x1Spoke in full sentencesToilet trainedPulled on clothesNeeded help with ADLsRead at 1st grade levelWrote and typedUsed iPadStrep infectionMensesAge 9First episode complex tics and choreiform movements w/ high strep titers, dx PANDAS and resolved with antibioticsThen rage outbursts and peri-menstrual aggressionThen depressive episode with severe anxiety and newgeneralized anxiety disorder3+ mood episodesNo lasting loss of skillsNo episode in past yearNo regressionCase 14Male16 years 6 monthsSequence variant -- NonsenseNM_033517.1:c.5008A \> T, p.Lys1670\* (this individual also has a likely benign missense variant in *SHANK3*, c.3872C \> T, p.Ser1291Leu)No speech, used PECSToilet trainedFed selfUsed iPadNavigated internetLiked musicNone notedAge 15First episode manicThen monthly manic episodesThen severe aggression requiring hospitalization and residential care20+ manic episodesAge 15Lost toilet trainingAverse to touchLost computer skillsLost social interestNo episode in past year18 months since regressionModerate recovery of toileting, self-feeding, some computer skillsCase 15Female28 years 11 monthsTerminal deletion \[43 kb\]arr\[hg18\] 22q13.33(49,479,705-49,522,868)x1Single wordsNever toilet-trainedCould change own pull-upDress selfDrink from cupSchool re-entryPossible URIsAge 9First episode manicThen manic spells with OCD behaviorsThen depressed periods with new aggression10+ mood episodesAge 24Lost ability to:Dress selfChange pull-upDrink from cupThree years since last episodeFour years since regressionNo recoveryCase 16Female15 years 1 monthSequence variant -- Frameshiftarr\[hg19\] 22q13.33(51,121,452-51,197,838)x1Spoke in full sentencesToilet trainedDressed selfReadPretend playWrote in cursiveKarateMensesAge 13First episode manic with paranoiaThen depressive episode with catatonia requiring ICU care and ECTThen recurrent manic episodesFive+ mood episodesNo lasting loss of skillsMood episode in past yearNo regressionCase 17Female13 years 10 monthsTerminal deletion \[4.3 Mb\]arr\[hg19\] 22q13.31q13.33(46,928,208-51,224,252)x1 dnSingle words or short phrasesToilet trainedDressed selfFed selfRode scooterMensesAge 13First episode depressed with catatoniaThen mania with urinary frequency and occasional incontinence, changes in gait and postureFour mood episodesNo lasting loss of skillsMood episode in past yearNo regressionCase 18Male20 years 10 monthsTerminal deletion \[76 kb\]arr\[hg19\] 22q13.33(51,121,452-51,197,838)x1Spoke in full sentencesToilet trainedDressed selfShowered selfRead at 3rd grade levelWrote sentencesUsed calculatorUsed iPhone to call/text friendsPossibly his increased awareness of deficitsAge 16First episode mixed mood disturbance with sleepiness and irritabilityThen mania alternating with depression and severe aggressionThree+ mood episodesAge 16ConfusedNeeds constant supervisionCannot dry selfPuts clothes on while still wetDecreased academic skillsUrinary incontinenceLost interest in usual activitiesMood episode in past yearFour years since regressionNo recoveryCase 19Male26 years 5 monthsSequence variant -- NonsenseNM_033517.1:c.1572C\>A, p.Cys524\*Spoke in full sentencesToilet trainedIndependent for ADLs and travel with school groupsReading at 3rd grade levelAttended community collegeCompetitive tennisMarathonerSchool transitionAge 17First episode manic with irritability, confusion, catatonia and new aggressionThen multiple manic and depressed episodesPsychotic features occurring between mood episodes20+ mood episodesAge 17Gradual, lost most speechOften incontinentLost ability to perform ADLsRequires constant 1:1 supervisionMood episode in past year12 years since regressionNo recoveryCase 20Female17 years 1 monthSequence variant -- FrameshiftNM_033517.1:c.4065_4066delTG, p.Val1357Glyfs\*4 dnPhrase speechAsked for needsToilet trainedFed selfStrep infectionAge 14First episode OCD with enuresis at night, aggression and sub-threshold manic symptomsThen similar episodes of OCD with manic symptomsLater diagnosis of autoimmune encephalitisThree+ mood and OCD episodesAge 15Decreased intelligibilityDecreased toiletingDecreased communicationDecreased feeding selfMood episode in past yearTwo years since regressionModerate recovery of speech clarity and toileting skillsCase 21Female(twin of case 20)17 years 1 monthSequence variant -- FrameshiftNM_033517.1:c.4065_4066delTG, p.Val1357Glyfs\*4 dnPhrase speechToilet trainedFed selfDressed selfRead a few sight wordsBasic writingStrep infectionAge 14First episode anxiety/OCD, transient inability to speak, then developed maniaThen diagnosed with PANDAS, Then catatoniaFive+ mood episodesAge 14Slow onsetDecreased toiletingDecreased communicationDecreased orientationDecreased feeding selfNo longer writes nameMood episode in past yearTwo years since regressionModerate recovery of communication and self-care skillsLess improvement with academicsCase 22Female15 years 0 monthTerminal deletion \[62 kb\]arr\[hg18\] 22q13.33(49,406,251-49,468,408)x1Few single wordsNot toilet trainedNeeded help for dressingFed self with utensilsNone notedAge 8First episode manic,then depressive episodes10+ episodesNo lasting loss of skillsMood episode in past yearNo regressionCase 23Female39 years 5 monthsTerminal deletion \[2.5 Mb\]arr\[hg18\] 22q13.32q13.33(47,003,473-49,515,911)x1Phrase speech with poor articulationToilet trainedIntact ADLsRead simple booksMemory gamesJigsaw puzzlesDot-to-dot coloringNone notedAge 32First episode depressedThen recurrent depressed episodes with severe anxiety, SIBThen mania with catatonia10+ mood episodesNo lasting loss of skillsMood episode in past yearNo regressionCase 24Female36 years 7 monthsTerminal deletion \[69 kb\]arr\[hg19\] 22q13.33(51,128,324-51,197,766)x1Phrase speechToilet trainedDressed selfFed selfRead simple textWrote at a second grade levelPubertyAge 15First episode agitation, OCD Then catatonia and depressionThen manic episodes10+ mood episodesAge 18Decreased urinary continenceDecreased independence for ADLsLost all academic skillsNo episodes in past year18 years since regressionNo recoveryCase 25Female24 years 1 monthTerminal deletion -- unbalanced translocation \[6.0 Mb\]46,XX,der(22)t(22;acro)(q13.33;p12); arr\[hg19\] 22q13.31q13.33(45,156,254-51,197,725)x1Single wordsToilet trainedFed selfDid choresMultiple family health stressorsHigh strep titersAge 21First episode depressed with agitation, photophobia, then catatonia, diagnosed PANDASOne episodeNo loss of skillsNo episode in 3 yearsNo regressionCase 26Male18 years 1 monthSequence variant--FrameshiftNM_033517.1:c.4649_4653dupGCAGC, p.Pro1552Alafs\*14 dn (based on the results of his monozygotic twin brother)Spoke in full sentencesToilet trainedDressed with assistanceFed selfRead fluentlyActed out playsUsed computer with sophistication (e.g., booked travel)Strep infectionAge 13First episode manic with acute onset insomnia, tics, anorexia diagnosed PANDASThen new pica, catatoniaThen mutism and aggression associated with recurrence of manic symptoms10+ mood episodesAge 13Lost languageDecreased fine motor skillsDecreased toiletingDecreased utensil useDecreased interest in people and hobbiesDestructiveSleep disruptedMood episode in past yearFive years since regressionMinimal recoverySlightly improved language and toiletingRemains socially withdrawnHas not regained fine motor skillsCase 27Male(twin of case 26)18 years 1 monthSequence variant -- FrameshiftNM_033517.1:c.4649_4653dupGCAGC, p.Pro1552Alafs\*14 dnPhrase speechToilet trainedNeeded help with dressingFed self with fingersUsed computerFew sight wordsStrep infectionAge 13First episode manic with acute onset insomnia, tics, anorexia diagnosed PANDASThen depression and catatonia10+ manic and depressed episodesAge 13Lost most language IncontinentDecreased feeding selfDecreased interest in people, activitiesMood episode in past yearFive years since regressionModerate recoveryHas regained some fine motor skills and social interests, but not language and full continenceCase 28Female26 years 3 monthsTerminal deletion \[70 kb\]arr\[hg19\] 22q13.33(51,127,898-51,197,838)×1Spoke in full sentencesToilet trainedIndependent with dressing and careTook own medsBlack belt in karateMensesAge 16Gradual onset aggressionThen manic episodes with unsafe behaviors10+ manic episodesAge 18Became confused about daily tasks and had trouble with self-careLanguage deterioratedEpisodes of running awayManic episode in past yearSix years since regressionHas recovered all skillsCase 29Female16 years 7 monthsSequence variant -- FrameshiftNM_033517.1:c.3679dupG, p.Ala1227Glyfs\*69 dnSpoke in full sentencesToilet trainedDressed selfIndependent for hygieneFed selfRead at 2nd grade levelMensesHashimoto's encephalopathyAge 12Gradual onset confusion and choking spells unrelated to foodThen episodes of mania and OCD with catatonia and disorganized behavior and new behavior posing risk of accidental injury10+ mood episodesAge 12Lost all adaptive skills, including continence and speechLost all academic skillsManic episode in past yearFour years since regressionMinimal recovery of relatedness and communicationNo recovery of academic skillsDependent for ADLsRequires constant supervisionAppears to understand language but little speechPlays simple computer gamesCase 30Female16 years 8 monthsTerminal deletion with interstitial duplication \[6.4 Mb\]46,XX,del \[[@CR22]\](q13.3); arr\[hg18\] 22q13.31(43,276,438-49,691,432)x1, 22q13.31(42,835,935-43,272,271)x3Minimal languageToilet trained for urine in daytimeFed self with forkCould put on clothes if in correct positionMycoplasma pneumoniaAge 14First episode depressed with catatoniaThen OCD and manic symptomsFive+ mood episodesAge 15Lost daytime continenceLost interest in play and relatednessDecreased feeding selfDecreased vocalizationMood episode in past yearThree years since regressionModerate recoveryHas regained energy and vocalization, not daytime continenceCase 31Female49 years 9 monthsTerminal deletion \[5.0 Mb\](5 Mb terminal deletion with the breakpoint at 22q13.31)Spoke a few wordsToilet trainedFed selfAmbulatoryNone notedAge 14First episode manicThen repeated mood episodes at intervals of five or more yearsThree+ mood episodesAge 47Loss of skills with each psychiatric episode; recovered each time until age 47, then lost all languageLost ability to walkLost feeding skillsTwo years since last mood episode;Two years since regressionNo recoveryNo languageIncontinentCannot stand or walk, has difficulty maintaining sittingCannot feed selfNeeds total careCase 32Female31 years 11 monthsTerminal deletion \[76 kb\]46,XX; arr\[hg19\] 22q13.33(51,121,452-51,197,838)x1 dnSpoke in full sentencesToilet trainedIntact ADLsPlanned recipes and cookedWorked with young childrenRan with running groupVolunteered at nursing homeNone notedAge 14First episode anxiety/OCDThen maniaThen depression with slow recovery over 2 years followed by severe mood cycling years laterThree+ mood episodesNo loss of skillsMood episode in past year (resolving)No regressionCase 33Female41 years 0 monthTerminal deletion \[481 kb\]arr\[hg18\] 22q13.33(49,210,245-49,691,432)x1Single wordsNever toilet trainedFed selfUndressed and pulled on pantsRead sight wordsPoured drinksRode tricyclePlayed with dollsNone notedAge 7First episode bizarre behavior with agitation, disorientation and insomnia (possible brief psychotic episode)Then OCD and new pica, followed by mania10+ mood episodesAge 16Lost all meaningful speech; repeats wordsUnable to feed self, eats by lowering face to plateUnable to assist with dressingLost all playElopes frequentlyMood episode in past year25 years since regressionNo recoveryCase 34Female17 years 8 monthTerminal deletion \[53 kb\]arr\[hg19\] 22q13.33(51,144,903-51,197,838)x1Spoke in full sentencesToilet trainedFed selfDressed selfRetrieved and poured cerealDid puzzlesPlayed with LegosMultiple social stressorsAge 14First episode depressed with anorexia and incontinenceThen mania and new picaFive+ mood episodesAge 14Decreased speechDecreased playDecreased dressingDecreased continenceNo episode in past yearFour years since regressionModerate recovery of language, self-care and play skillsCase 35Female23 years 1 monthSequence variant -- FrameshiftNM_033517.1:c.4086_4087delAC, p.Arg1363Glnfs\*31Phrase speech with echolaliaToilet trainedFed selfPoured milkDressed self with assistanceNeeded help with ADLsPretend playMultiple social stressorsAge 12First episode depressed with confusion, new incontinence and catatoniaThen maniaThree+ mood episodesAge 12Steady ongoing regressionLost all speechIncontinentLost all self-care skillsMood episode in past year11 years since regressionNo recoveryRequires constant supervisionOnly able to walk short distances with difficultyCannot climb stairsCase 36Female15 years 0 monthSequence variant -- FrameshiftNM_033517.1:c.4065_4066delTG, p.Val1357Glyfs\*4 dnSpoke in full sentencesToilet trainedDressed selfFed selfRead sight wordsUsed tabletMath at 1st grade levelSocial stressorsAge 14First episode catatonic with urinary retention, insomnia and pica; did not recognize family; paranoidOne episodeStill recovering from first episode with catatonia; cannot yet determine new baseline or whether lost skills meet criteria for regressionEight months since onset of psychiatric illnessContinues to regain language, personality, and orientationStill not able to open and use hands for ADLsIntermittently incontinentCase 37Female17 years 5 monthsSequence variant -- NonsenseNM_033517.1:c.4333C \> T, p.Gln1445\* dnPhrase speechToilet trainedFed selfDressed self with assistanceImaginative playWrote nameCopied textDrew picturesMensesEnd of school yearAge 15First episode depressed with insomnia, severe separation anxiety, apathy, decreased speech and interaction, swallowing difficulties, and catatoniaOne mood episodeAge 15Lost most speechLost ability to chew foodIncreased dependence for ADLsLost all academic skillsLost imaginary playNo episode in past yearTwo years since regressionModerate recoveryRegained some speechEats normallyMostly continentContinues to not have academic skills, drawing skills, or imaginary play skillsCase 38Female16 years 9 monthsSequence variant -- FrameshiftNM_033517.1:c.2763delG, p.Pro922Argfs\*34 dnSpoke in full sentencesToilet trainedSociableMensesUTIAge 13First episode hypomanicThen 2 years later manic with aggression, incontinence; anxiety, talking to self, compulsions, then catatoniaThree manic episodesAge 15Lost all speechLost ability to feed selfIncontinentDecreased social interactionNo episode in past yearOne year since regressionSubstantial recoveryRecovered languageRecovered feedingImproved social interactionContinues with intermittent incontinence*Abbreviations*: *ADLs* activities of daily living, *dn* de novo, *dx* diagnosis, *ECT* electroconvulsive therapy, *ICU* intensive care unit, *OCD* obsessive-compulsive disorder, *PANDAS* pediatric autoimmune neuropsychiatric disorder associated with streptococcus, *PECS* Picture Exchange Communication System, *UTI* urinary tract infection, *URI* upper respiratory tract infection^**1**^ All were ambulatory and able to feed themselves with utensils prior to psychiatric illness^**2**^ Cases 11, 14, 17, 22, 30, 33, and 35 had regression in speech, play, and social interaction before age 8, as well as subsequent regressions accompanying psychiatric illness at an older age^3^ Regression defined as loss of skills that persisted at least 6 months after resolution of acute psychiatric episode^**4**^ Regression occurred years after onset of psychiatric illness^5^ "Symptoms" used when sub-threshold for diagnosis of either depressive or manic episode

As compared with the 509 PMSIR registrants not in this study who had genetic data available, sequence variants in *SHANK3* were present at higher rates in our sample (39% \[15/38\] vs 6% \[32/509\]; Fisher's exact test, *p* = 4 × 10^− 8^), and conversely, terminal deletions were less frequent (61% \[23/38\] vs 92% \[467/509\]; Fisher's exact test, *p* = 8 × 10^− 7^). Comparisons with 130 PMSIR registrants of similar age with questionnaire data available are also reported in Table [1](#Tab1){ref-type="table"}. In addition, deletions tended to be smaller in the participants of this study than in the PMSIR (mean size 1.634 Mb vs 3.633 Mb; unpaired two-tailed Student's *t* test, *p* = 0.0019). In particular, individuals with small deletions, defined as those including at most the four distal genes, *ARSA*, *SHANK3*, *ACR*, and *RABL2B*, are over-represented among study participants compared to the PMSIR (57% \[12/21 deletions with size information\] vs 19% \[72 /387\]; Fisher's exact test, *p* = 1.6 × 10^− 4^). (Heterozygous loss of *ARSA*, *ACR*, and *RABL2B* does not contribute to the PMS phenotype, so deletions including these genes are equivalent to deletions involving only *SHANK3.*)

Developmental history {#Sec6}
---------------------

Although documentation of the severity of ID was not available, reported levels of adaptive functioning suggest that mild to moderate ID was common in this sample prior to the onset of psychiatric symptoms and regression and that these individuals were less impaired prior to their psychiatric illness as compared to the PMSIR reference sample (Table [1](#Tab1){ref-type="table"}). Prior to the onset of psychiatric illness, study participants were significantly more likely than participants in the PMSIR sample to ever have walked independently, achieved toilet training, verbal expression with at least phrase speech, and independence with dressing.

Psychiatric illness {#Sec7}
-------------------

Psychiatric difficulties began between ages 10 and 18 in the majority of cases (28/38; 74%). Psychiatric symptoms emerged between the ages of 7 and 10 years in 5/38 cases (13%), while 5/38 cases (13%) developed psychiatric symptoms between ages 21 and 32. Using the DM-ID-2, first episodes met criteria for a manic episode in 17/38 cases (45%) and for a depressive episode in 14/38 cases (37%). First episodes in the remaining cases included six (16%) with a mixture of mood and anxiety symptoms, and one case of disorganized, bizarre behavior that suggested a brief psychotic episode.

Most participants (27/38; 71%) had experienced a mood episode in the year before the study. The aftermath of acute episodes was associated with higher baseline levels of anxiety and irritability and with regression. Subsequent psychiatric episodes were superimposed and caregivers clearly distinguished episodes from baseline states. First episodes ranged from 8 months to 35 years before study participation. Reported episode length varied from periods of days to months. Most cases (34/38; 89%) had multiple distinct episodes consistent with a mood disorder, including 12 of 38 (32%) with two to four distinct episodes, 6 of 38 (16%) with five to nine episodes, and 16 of 38 (42%) with more than ten episodes (see Table [2](#Tab2){ref-type="table"} for details). Few cases (4/38; 11%) reported only a single psychiatric episode; all four of these were within the 3 years prior to study participation.

Twenty-nine of 38 cases (76%) reported a manic episode at some point in their illness; 24 of 38 (63%) reported both manic and depressive episodes. Nineteen of 38 cases (50%) were reported to have had psychotic symptoms during an acute mood episode. One participant presented with both depressive and manic episodes and with psychosis in between mood episodes, suggesting schizoaffective disorder.

New anxiety symptoms accompanied mood episodes in the majority of participants (26/38; 68%). Six participants (16%) met criteria for obsessive-compulsive disorder at some point in the course of their illness. Four participants (11%) met criteria for generalized anxiety disorder. Only two participants (5%) had first episodes that were predominantly anxious.

Symptoms consistent with a diagnosis of catatonia associated with another mental disorder were reported in 20 of 38 cases (53%). Seven of the 20 (35%) were on neuroleptics at the time of emergence of catatonic symptoms. Cases with sequence variants in *SHANK3* met diagnostic criteria for catatonia significantly more often (12/15; 80%) than cases with terminal deletions (8/23; 35%) (Fisher's exact test, *p* = 0.009).

Regression {#Sec8}
----------

The interview explored both abilities lost and the degree of return of skills over time. Caregivers were asked which skills were lost, at what age, and which, if any, skills were regained. Seven of the participants (18%) had experienced regressions in early childhood affecting communication, social interaction, and/or imaginative play (five by age two, one at age four, one at age seven), but we do not elaborate on those early regressions in the current report. Analysis focused on the 25 of 38 cases (66%) who had regressions that began within the 3 years after the onset of psychiatric episodes. Most of these regressions (21/25; 84%) began within a year after the onset of psychiatric episodes and involved multiple domains of function. Descriptions of the areas of skill lost and recovery are summarized in Table [2](#Tab2){ref-type="table"}, which includes developmental status in terms of speech, toilet training, ability to dress and wash self, academic skills, and vocational activities when present. Caregiver reports of recovery of skills ranged from continuing loss of further skills to complete return to baseline function before the onset of psychiatric symptoms. Overall, more than half of the participants who regressed in the 3 years after the onset of psychiatric illness reported minimal recovery (14/25; 56%).

Antecedents to the onset of psychiatric illness and regression were explored in the interview. Menstrual cycling was reported to play a triggering role in 11 of 31 (35%) of the females. Acute infections were suspected triggers in 11 of 38 cases (29%). Psychosocial stressors were suspected triggers in 10 of 38 cases (26%). Several participants reported differing antecedent stressors for different episodes.

Co-morbid conditions {#Sec9}
--------------------

Only a quarter (9/38; 24%) of study participants was known to have PMS before the onset of psychiatric symptoms and associated regression. Sixteen cases (42%) had diagnoses of ASD before the onset of psychiatric symptoms and regression; five more received an ASD diagnosis after the onset of psychiatric illness and regression.

Fifteen of 38 cases (40%) reported one or more afebrile seizure. Eight of those 15 cases (53%) reported a seizure in the 2 years preceding the interview. Fifteen of 38 cases (40%) had weight loss of 10 to 25 kg accompanying psychiatric episodes. Chronic constipation, intermittent urinary incontinence, and episodes of acute urinary retention were prevalent in this sample, particularly as subjects aged. Chronic constipation was noted in 32 cases (84%), with episodes of acute urinary retention reported in 18 (47%). The discomfort associated with these conditions may lead to non-specific behaviors such as agitation, aggression, and self-injury in people with ID; these chronic symptoms were not coded as mood episodes. A small subset of subjects (4/38; 11%) had an immune-related disorder. Two participants (5%) were diagnosed with Hashimoto's thyroiditis, one of whom was diagnosed with Hashimoto's encephalopathy, and two participants (5%) had immunoglobulin deficiency, including one with common variable immunodeficiency.

Therapeutic interventions {#Sec10}
-------------------------

At the time of interview, 32 of 38 participants (84%) were receiving one or more psychiatric medications, with 14 of 38 (37%) receiving four or more psychiatric medications. More than half (21/38; 55%) took anticonvulsants; all of these had mood symptoms, while 12 also had a history of seizures. Over half (55%) were receiving neuroleptics. Benzodiazepines were used either regularly or on an as-needed basis in 16 of 38 cases (42%). Alpha agonists, beta-blockers, antihistamines, and trazodone were prescribed for sleep or aggression. Smaller numbers of participants were receiving selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, buspirone, lithium, cannabinoid oil, or n-acetylcysteine.

Full details of dosages and adjustments to treatment regimens in response to changing psychiatric status were inconsistently available and are therefore not reported. However, many parents kept extensive notes, and their reports of responses to medication trials suggest two patterns worth noting: (1) participants were reported to be sensitive to side effects from neuroleptics, with adverse events including extrapyramidal symptoms, worsening aggression and/or onset of catatonic symptoms reported in 14 of 30 cases (47%), while (2) seven of nine participants (78%) treated with SSRIs for depressive symptoms developed agitation, aggression, or other manic-like symptoms within weeks of the start of treatment.

Three individuals were treated with electroconvulsive therapy (ECT) for catatonia with reported significant benefit; two continue to require maintenance ECT (duration of treatment 18 months in one, \> 8 years in the other) while the third discontinued after initial response due to agitation. One participant with recurrent catatonia on maintenance ECT was reported to have also benefited from intravenous immunoglobulin (IVIG) with improved cognition and motivation, but developed aseptic meningitis and a rash after the fifth treatment, leading to discontinuation of IVIG.

Nine participants (26%) were reported to have received immunomodulatory treatments for diagnoses of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) syndrome or of autoimmune encephalopathy. Six were diagnosed with PANDAS syndrome on the basis of clinical symptoms and positive strep cultures or elevated titers. One participant was diagnosed with Hashimoto's encephalopathy, and two with seronegative autoimmune encephalitis. Treatments included (1) antibiotics, (2) IVIG, and/or (3) systemic anti-inflammatories such as nonsteroidal anti-inflammatory drugs, steroids, or rituximab.

In four of six cases diagnosed with PANDAS syndrome, parents reported that antibiotic treatment was effective in reducing or eliminating acute symptoms. The remaining two improved slowly; one also received IVIG and the other received lorazepam; these parents were not confident that antibiotics had played a role in recovery. Treatment for PANDAS symptoms did not appear to prevent future mood episodes or regression, as all but one of these cases went on to have further psychiatric episodes and some had later regressions. The one participant diagnosed with Hashimoto's encephalopathy continues to receive regular infusions of IVIG with steroids, as well as rituximab. The two participants with diagnoses of seronegative autoimmune encephalopathy receive monthly IVIG.

Eight females were on hormonal therapy to eliminate menstrual cycles and reduce associated mood symptoms. Non-pharmacological treatments varied widely by geographic location and age, with those still in school more likely to be receiving structured behavioral interventions. Data on past and current behavioral programs and therapies were not included in the interview.

Discussion {#Sec11}
==========

This case series has characterized a subset of individuals with PMS who have episodic, severe neuropsychiatric illness, frequently beginning in adolescence or early adulthood, with major impacts on functional status. The symptoms and course of illness often closely resembled bipolar illness, with psychotic features almost exclusively present in the context of mood episodes. None of the participants in our sample presented with a primary psychotic disorder, such as schizophrenia. However, one participant presented with distinct psychotic and affective episodes characteristic of schizoaffective disorder. Using the DM-ID-2 criteria \[[@CR30]\], all but one of the participants had either a mood disorder or an anxiety disorder, with multiple discrete periods of illness in all but four.

Several triggers were often reported as temporal antecedents to the onset of psychiatric changes. Biological triggers included infections and changes in hormonal status, while environmental factors included stressful life events. Similar patterns have been observed in other, more common neurogenetic syndromes, including Down syndrome \[[@CR32]\], Williams syndrome \[[@CR33]\], and 22q11.2 deletion syndrome \[[@CR34]\].

It is critical to emphasize the high incidence of catatonic symptoms in this subset of individuals with PMS, as catatonia often goes unrecognized or undertreated in individuals with developmental disabilities \[[@CR25], [@CR35]\]. Recognition and treatment of both stuporous and hypermotoric catatonia is crucial, as symptoms can lead to life-threatening complications. Other genetic conditions involving copy number variants, such as 22q11.2 deletions \[[@CR36]\], have also been associated with psychiatric symptoms and with catatonia. Similar to their use in treating catatonia in other conditions, benzodiazepines and ECT were used in this cohort with reported tolerability and effectiveness.

Regression has long been recognized in neurodevelopmental disorders such as ASD \[[@CR37]\], but the triggers and mechanisms are not well understood, and the literature focuses largely on early childhood regression, especially as it relates to Rett syndrome \[[@CR37]--[@CR40]\]. Significant cognitive and behavioral regression has been documented in PMS \[[@CR5], [@CR6], [@CR9], [@CR15], [@CR16], [@CR18], [@CR41]\]. Verhoeven et al. \[[@CR20]\] have recently published on the course of illness of 24 adolescents and adults with PMS referred for evaluation and treatment of "challenging behaviors and unstable mood." In that sample, there were five individuals with periodic catatonic symptoms, and four other individuals who developed progressive loss of skills in their third or fourth decade.

Two thirds (66%) of our sample described lasting regressions that began within 3 years of the onset of psychiatric illness. These regressions in communication, self-care, and motor functions left a subset of previously more capable individuals largely non-verbal, incontinent, and unable to dress or feed themselves. Many of these participants continue to experience episodic psychiatric illness in addition to developmental decline. Interestingly, a similar combination of rapid onset psychiatric disturbance with marked regression and catatonia has been described in Down syndrome \[[@CR42], [@CR43]\] and subsequently labeled "Down syndrome disintegrative disorder." A recent case series \[[@CR44]\] documented a role for immunotherapy in restoring function and stability in these individuals, although it is also recognized that cognitive decline in Down syndrome relates to amyloid precursor protein gene triplication \[[@CR45]--[@CR47]\]. Regression in PMS may be more common than in Down syndrome, and its potentially devastating impact warrants ongoing study of the natural history, mechanism, and targets for intervention.

Given the methodological limitations and sample selection bias in this study, we are unable to draw conclusions about the prevalence of psychiatric illness and/or regression among people with PMS. This study was also limited by the lack of standardized or validated tools to measure neuropsychiatric symptoms in severely developmentally disabled children and adults. However, within this self-referred subset of individuals with PMS whose caregivers identified psychiatric illness, we observed a distinct pattern of affective episodes, with onset typically in puberty, a strikingly high incidence of catatonic symptoms, and an association with substantial regression in the second through fourth decades of life. Of note, a recent literature review analyzed prior reports of 56 individuals with PMS with accompanying neuropsychiatric symptoms, and concluded that "clinicians and caregivers need to be vigilant for loss of skills and neuropsychiatric changes in adolescents and adults with PMS, including the development of bipolar disorder and catatonia" \[[@CR48]\].

Individuals with PMS who present with new psychiatric symptoms require careful monitoring and cautious early intervention. Response to traditional psychiatric interventions is variable, and the role for immunomodulatory treatments and ECT in specific subsets of patients should be explored in future studies. The pattern of rapid and severe deterioration described in more than half of this group calls for further investigation to identify triggers and the underlying biology and to delineate possible strategies for prevention and timely intervention. While the current study does not allow for specific treatment recommendations, there is an urgent need for clinical trials to assess the efficacy of existing psychopharmacological treatments for psychiatric symptoms in PMS, in addition to developing novel, targeted therapeutics.

The preponderance of females in this sample (\> 4:1) is notable and calls for replication. Sequence variants in *SHANK3* were also six times more common in this sample than in the PMSIR. These findings raise questions about whether psychiatric problems and regression disproportionately affect females and/or individuals with *SHANK3* sequence variants, in contrast to those with deletions. In addition, prior to the onset of psychiatric illness, most of the participants described herein were less severely impaired in their adaptive functioning than is reported in most studies of PMS. This finding is likely related to the high proportion of individuals with *SHANK3* variants and small deletions in this sample.

Further studies should attempt to clarify if psychiatric difficulties are actually more common in individuals who are more verbal and social and who have more intact adaptive functioning at baseline, or, whether this finding is the result of selection bias in our sample, as the majority of participants (76%) were only diagnosed with PMS after the onset of psychiatric symptoms.

Finally, our sample underscores the importance of genetic testing as part of the medical work-up for individuals with this presentation. Chromosomal microarray is recommended for the evaluation of all children with global developmental delay or intellectual disability \[[@CR49]\]. In the setting of superimposed psychiatric illness or regression, chromosomal microarray should be considered as first tier testing, followed by sequencing of *SHANK3* if the microarray is unrevealing.

Conclusion {#Sec12}
==========

This study confirms that individuals with PMS are at risk of developing severe neuropsychiatric illness in adolescence or early adulthood. In most cases, the symptoms appear consistent with the expression of bipolar disorder in individuals with intellectual disability, with catatonia noted as a common co-occurring condition. Triggers may include infections, changes in hormonal status, and stressful life events. Significant cognitive and behavioral regression beyond a baseline level of disability has been previously reported in PMS and accompanied the onset of psychiatric illness in a majority of the cases reported here. Our results must be interpreted with caution given the potential selection bias in recruitment, but it is clear that people with PMS may show a rapid and severe deterioration that requires careful monitoring and intervention. Our findings also highlight the relevance of genetic testing in the work-up of individuals with intellectual disability and acute psychiatric illness or regression. Future research is needed to clarify the prevalence and nature of psychiatric symptoms and regression among larger unbiased samples of individuals with PMS and to delineate any shared mechanisms with other neurodevelopmental disorders presenting with psychiatric illness and/or regression in adolescence or early adulthood. Identification of early clinical and biological markers would contribute to our understanding of the underlying neurobiology of these disorders and potentially aid in monitoring, early intervention, or prevention.
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 {#Sec13}

Additional file 1.Caregiver Interview for Psychiatric Illness in Persons with ID (CIPIPID) Additional file 2.Adapted Diagnostic Criteria, DM-ID-2

ASD

:   Autism spectrum disorder

DM-ID-2

:   Diagnostic Manual - Intellectual Disability, Second Edition

ECT

:   Electroconvulsive therapy

ID

:   Intellectual disability

IVIG

:   Intravenous immunoglobulin

PANDAS

:   Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections

PMS

:   Phelan-McDermid syndrome

PMSIR

:   Phelan-McDermid Syndrome International Registry
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